ERBB2 and cancer: For example, over-expression of the receptor tyrosine kinase (RTK), human epidermal growth factor 2 (HER-2) by gene amplification, is linked to an aggressive cancer cell subtype by inducing up-regulation of a key lipogenic enzyme, the fatty acid synthase (FASN).